{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:38:52Z","timestamp":1794429532579,"version":"4.9.1"},"reference-count":139,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.euroneuro.2023.07.003","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T13:44:30Z","timestamp":1689169470000},"page":"3-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["The potential of psychedelics for the treatment of Alzheimer's disease and related dementias"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9936-348X","authenticated-orcid":false,"given":"Michael James","family":"Winkelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7833-8894","authenticated-orcid":false,"given":"Attila","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ede","family":"Frecska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2023.07.003_bib0001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pharmthera.2015.03.004","article-title":"DYRK1A in neurodegeneration and cancer: molecular basis and clinical implications","volume":"151","author":"Abbassi","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0002","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbi.2021.01.037","article-title":"Transcriptome analysis reveals disparate expression of inflammation-related miRNAs and their gene targets in iPSC-astrocytes from people with schizophrenia","volume":"94","author":"Akkouh","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0003","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.tips.2021.08.003","article-title":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","volume":"42","author":"Aleksandrova","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0004","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/157015911798376190","article-title":"The neurotrophins and their role in Alzheimer's disease","volume":"9","author":"Allen","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0005","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1091\/mbc.E20-05-0340","article-title":"Catalysts for change: the cellular neurobiology of psychedelics","volume":"32","author":"Banks","year":"2021","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116980","article-title":"Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention","volume":"218","author":"Barrett","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0007","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1742-4658.2010.07956.x","article-title":"Activation, regulation, and inhibition of DYRK1A","volume":"278","author":"Becker","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0008","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00441-006-0286-1","article-title":"Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation","volume":"326","author":"Bockaert","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0009","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/biom12030363","article-title":"Novel therapeutic target for prevention of neurodegenerative diseases: modulation of neuroinflammation with Sig-1R ligands","volume":"12","author":"Bogar","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0011","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/2061359a0","article-title":"Constituents of Amanita muscaria","volume":"206","author":"Bowden","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0012","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","article-title":"A non-hallucinogenic psychedelic analogue with therapeutic potential","volume":"589","author":"Cameron","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0013","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00213-014-3658-3","article-title":"The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice","volume":"232","author":"Carbonaro","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0014","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid-beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"Colovic","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0016","doi-asserted-by":"crossref","first-page":"e2727","DOI":"10.7717\/peerj.2727","article-title":"Harmine stimulates proliferation of human neural progenitors","volume":"4","author":"Dakic","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0017","doi-asserted-by":"crossref","first-page":"12863","DOI":"10.1038\/s41598-017-12779-5","article-title":"Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT","volume":"7","author":"Dakic","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0018","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3389\/fpsyg.2019.01234","article-title":"Modulation of serum brain-derived neurotrophic factor by a single dose of ayahuasca: observation from a randomized controlled trial","volume":"10","author":"De Almeida","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0019","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","article-title":"Propagation of tau pathology in a model of early Alzheimer's disease","volume":"73","author":"De Calignon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0020","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020705118","article-title":"Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission","volume":"118","author":"De Gregorio","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109836","article-title":"Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice","volume":"37","author":"De la Fuente Revenga","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.724606","article-title":"Psychedelics and neuroplasticity: a systematic review unraveling the biological underpinnings of psychedelics","volume":"12","author":"De Vos","year":"2021","journal-title":"Front. Psychiatry."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.790213","article-title":"The hallucinogenic serotonin2A receptor agonist, 2,5-dimethoxy-4-iodoamphetamine, promotes cAMP response element binding protein-dependent gene expression of specific plasticity-associated genes in the rodent neocortex","volume":"14","author":"Desouza","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2016.1260189","article-title":"Effects of the natural beta-carboline alkaloid harmine, a main constituent of ayahuasca, in memory and in the hippocampus: a systematic literature review of preclinical studies","volume":"49","author":"Dos Santos","year":"2017","journal-title":"J Psychoact. Drugs"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0025","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.neuron.2018.07.039","article-title":"Tau protein disrupts nucleocytoplasmic transport in Alzheimer's disease","volume":"99","author":"Eftekharzadeh","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0026","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1474-8673.2006.00368.x","article-title":"Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function","volume":"26","author":"Eglen","year":"2006","journal-title":"Auton. Autacoid Pharmacol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0027","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fncir.2018.00020","article-title":"Emergence of serotonergic neurons after spinal cord injury in turtles","volume":"12","author":"Fabbiani","year":"2018","journal-title":"Front. Neural. Circuits"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0028","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00213-019-05417-7","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers","volume":"237","author":"Family","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0029","series-title":"Fly Agaric: A compendium of history, pharmacology, Mythology and Exploration","author":"Feeney","year":"2020"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0030","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/acsptsci.0c00063","article-title":"Structure-activity relationship analysis of psychedelics in a rat model of asthma reveals the anti-inflammatory pharmacophore","volume":"4","author":"Flanagan","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0031","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/09540261.2018.1481827","article-title":"Psychedelics as anti-inflammatory agents","volume":"30","author":"Flanagan","year":"2018","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0032","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1038\/s41598-019-49987-0","article-title":"Activation of 5-HT2 receptors reduces inflammation in vascular tissue and cholesterol levels in high-fat diet-fed apolipoprotein E knockout mice","volume":"9","author":"Flanagan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0033","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/ijms20030488","article-title":"Morphing of ibogaine: a successful attempt into the search for sigma-2 receptor ligands","volume":"20","author":"Floresta","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0034","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00702-013-1024-y","article-title":"A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity","volume":"120","author":"Frecska","year":"2013","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006654","article-title":"The role of microbial amyloid in neurodegeneration","volume":"13","author":"Friedland","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0036","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/1568026023393525","article-title":"GABA(A) receptor ligands and their therapeutic potentials","volume":"2","author":"Frolund","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0037","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41593-018-0298-7","article-title":"A tau homeostasis signature is linked with the cellular and regional vulnerability of excitatory neurons to tau pathology","volume":"22","author":"Fu","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0038","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/7854_2021_267","article-title":"Psychedelics as novel therapeutics in Alzheimer's disease: rationale and potential mechanisms","volume":"56","author":"Garcia-Romeu","year":"2022","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0039","series-title":"World Alzheimer Report 2021: Journey through the Diagnosis of Dementia","author":"Gauthier","year":"2021"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0040","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jagp.2019.03.008","article-title":"Imagining a role for psychedelics in dementia care","volume":"27","author":"George","year":"2019","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0041","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1126\/science.aau0437","article-title":"Alzheimer's disease: the right drug, the right time","volume":"362","author":"Golde","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0042","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid-beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0043","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","article-title":"Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens","volume":"61","author":"Halberstadt","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0044","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0045","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1523\/JNEUROSCI.3959-04.2005","article-title":"Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption","volume":"25","author":"He","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0046","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1096\/fj.06-6394fje","article-title":"Autoregulation of glial cell line-derived neurotrophic factor expression: implications for the long-lasting actions of the anti-addiction drug, ibogaine","volume":"20","author":"He","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0047","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fcvm.2017.00048","article-title":"The effects of serotonin in immune cells","volume":"4","author":"Herr","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0048","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/TGR.0b013e31821e588e","article-title":"Plasticity in early Alzheimer's disease: an opportunity for intervention","volume":"27","author":"Hill","year":"2011","journal-title":"Top Geriatr. Rehabil."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0049","series-title":"The Dream Drugstore: Chemically Altered States of Consciousness","author":"Hobson","year":"2001"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0050","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0051","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/acsptsci.0c00099","article-title":"Low doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers","volume":"4","author":"Hutten","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0052","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fphar.2018.00330","article-title":"Hypothesis: the psychedelic ayahuasca heals traumatic memories via a sigma 1 receptor-mediated epigenetic-mnemonic process","volume":"9","author":"Inserra","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110594","article-title":"Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of d-lysergic acid diethylamide (LSD): impact on neurotropic, neurotrophic, and neuroplasticity signaling","volume":"119","author":"Inserra","year":"2022","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0054","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","article-title":"Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms","volume":"73","author":"Inserra","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0055","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/0269881120959614","article-title":"Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin","volume":"35","author":"Jefsen","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0056","first-page":"00501","article-title":"The safety and efficacy of psychedelic-assisted therapies for older adults: knowns and unknowns","volume":"S1064-7481","author":"Johnston","year":"2022","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0057","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1007\/s11064-014-1245-y","article-title":"Muscimol as an ionotropic GABA receptor agonist","volume":"39","author":"Johnston","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0058","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnsyn.2020.00034","article-title":"Psychedelics as a treatment for Alzheimer's disease dementia","volume":"12","author":"Jones","year":"2020","journal-title":"Front. Synaptic. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0059","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0060","first-page":"575","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement NY"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0061","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0062","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrd4295","article-title":"Muscarinic acetylcholine receptors: novel opportunities for drug development","volume":"13","author":"Kruse","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0063","series-title":"The Science of Citizen Science","first-page":"243","article-title":"Participants in citizen science","author":"Land-Zandstra","year":"2021"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0064","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neures.2005.04.008","article-title":"Chronic stimulation of GABAA receptor with muscimol reduces amyloid beta protein (25-35)-induced neurotoxicity in cultured rat cortical cells","volume":"52","author":"Lee","year":"2005","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0065","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41467-020-20112-4","article-title":"Transneuronal delivery of hyper-interleukin-6 enables functional recovery after severe spinal cord injury in mice","volume":"12","author":"Leibinger","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0066","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0067","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/brain\/124.10.2105","article-title":"Lidocaine and muscimol microinjections in subthalamic nucleus reverse Parkinsonian symptoms","volume":"124","author":"Levy","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0068","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","article-title":"TREM2 function impedes tau seeding in neuritic plaques","volume":"22","author":"Leyns","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0069","article-title":"Harmine impairs memory performance of treated rats and nontreated cagemates","author":"Libanio","year":"2021","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0070","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fnmol.2018.00312","article-title":"A single dose of 5-MeO-DMT stimulates cell proliferation, neuronal survivability, morphological and functional changes in adult mice ventral dentate gyrus","volume":"11","author":"Lima da Cruz","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0071","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.tig.2014.09.003","article-title":"Can changes in histone acetylation contribute to memory formation?","volume":"30","author":"Lopez-Atalaya","year":"2014","journal-title":"Trends Genet."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0072","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1212\/01.WNL.0000038385.60538.19","article-title":"Elevation of blood beta-carboline alkaloids in essential tremor","volume":"59","author":"Louis","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0073","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.748359","article-title":"Serotonergic psychedelics in neural plasticity","volume":"14","author":"Lukasiewicz","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0074","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0075","doi-asserted-by":"crossref","first-page":"PL57","DOI":"10.1016\/0024-3205(95)00301-L","article-title":"Ibogaine possesses a selective affinity for \u03c32 receptors","volume":"57","author":"Mach","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0076","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0077","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212280","article-title":"Epigenetic mechanisms in memory and cognitive decline associated with aging and Alzheimer's disease","volume":"22","author":"Maity","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0078","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ebiom.2016.08.049","article-title":"Psychedelics recruit multiple cellular types and produce complex transcriptional responses within the brain","volume":"11","author":"Martin","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0079","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/7854_2017_479","article-title":"The effects of hallucinogens on gene expression","volume":"36","author":"Martin","year":"2018","journal-title":"Curr. Top Behav. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fphar.2019.00193","article-title":"Ibogaine administration modifies GDNF and BDNF expression in brain regions involved in mesocorticolimbic and nigral dopaminergic circuits","volume":"10","author":"Marton","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0081","series-title":"Nuts and Seeds in Health and Disease Prevention","first-page":"585","article-title":"Medicinal and pharmacological potential of harmala (Peganum harmala L.) seeds","author":"Marwat","year":"2011"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0082","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/164_2017_15","article-title":"Sigma-1 (\u03c31) receptor in memory and neurodegenerative diseases","volume":"244","author":"Maurice","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0083","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fnsyn.2017.00002","article-title":"Modulation of synaptic plasticity in the cortex needs to understand all the players","volume":"9","author":"Meunier","year":"2017","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0084","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S0953756203007305","article-title":"Amanita muscaria: chemistry, biology, toxicology, and ethnomycology","volume":"107","author":"Michelot","year":"2003","journal-title":"Mycol. Res."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0086","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1038\/s41598-017-05407-9","article-title":"The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro","volume":"7","author":"Morales-Garcia","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0087","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.3390\/ijms23169328","article-title":"Antioxidant therapeutic strategies in neurodegenerative diseases","volume":"23","author":"Moren","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0088","doi-asserted-by":"crossref","first-page":"e60863","DOI":"10.1371\/journal.pone.0060863","article-title":"Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice","volume":"8","author":"Moriguchi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113245","article-title":"N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats","volume":"327","author":"Nardai","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0090","doi-asserted-by":"crossref","first-page":"e75426","DOI":"10.1371\/journal.pone.0075426","article-title":"Serotonin 5-HT2A receptor activation blocks TNF-alpha mediated inflammation in vivo","volume":"8","author":"Nau","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0091","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0092","series-title":"Essential Guide to N-of-1 Trials in Health","author":"Nickles","year":"2015"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0093","first-page":"97","article-title":"The role of sigma-1 receptor, an intracellular chaperone in neurodegenerative diseases","volume":"16","author":"Penke","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0094","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejphar.2017.11.012","article-title":"Very low doses of muscimol and baclofen ameliorate cognitive deficits and regulate protein expression in the brain of a rat model of streptozocin-induced Alzheimer's disease","volume":"818","author":"Pilipenko","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2193-1801-4-S1-P36","article-title":"GABAA agonist muscimol ameliorates learning\/memory deficits in streptozocin-induced Alzheimer's disease non-transgenic rat model","volume":"4","author":"Pilipenko","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0096","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.euroneuro.2016.01.005","article-title":"Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A\/2A agonist ergotamine on psilocybin-induced psychedelic experience","volume":"26","author":"Pokorny","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0097","doi-asserted-by":"crossref","first-page":"e35082","DOI":"10.7554\/eLife.35082","article-title":"Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor","volume":"7","author":"Preller","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0098","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.biopsych.2019.12.027","article-title":"Psilocybin induces time-dependent changes in global functional connectivity","volume":"88","author":"Preller","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0099","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1073\/pnas.1815129116","article-title":"Effective connectivity changes in LSD-induced altered states of consciousness in humans","volume":"116","author":"Preller","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0100","doi-asserted-by":"crossref","first-page":"e9019","DOI":"10.1371\/journal.pone.0009019","article-title":"Psychedelics and the human receptorome","volume":"5","author":"Ray","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0101","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jnc.15587","article-title":"The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT)","volume":"162","author":"Reckweg","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0102","doi-asserted-by":"crossref","first-page":"eaao4827","DOI":"10.1126\/science.aao4827","article-title":"Secreted amyloid-beta precursor protein functions as a GABABR1a ligand to modulate synaptic transmission","volume":"363","author":"Rice","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0103","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0104","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnhum.2014.00204","article-title":"The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers","volume":"8","author":"Roseman","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0105","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.687615","article-title":"Ceremonial ayahuasca in amazonian retreats-mental health and epigenetic outcomes from a six-month naturalistic study","volume":"12","author":"Ruffell","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0106","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.nbd.2018.12.022","article-title":"Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor","volume":"124","author":"Ryskamp","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0107","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fnins.2019.00862","article-title":"Neuronal sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases","volume":"13","author":"Ryskamp","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0108","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/jnc.15544","article-title":"Psychedelic-inspired approaches for treating neurodegenerative disorders","volume":"162","author":"Saeger","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0109","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41593-022-01213-3","article-title":"Serotonin regulation of behavior via large-scale neuromodulation of serotonin receptor networks","volume":"26","author":"Salvan","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0110","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ijnp\/pyx036","article-title":"Assessing the psychedelic \"after-glow\" in ayahuasca users: post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities","volume":"20","author":"Sampedro","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.euroneuro.2023.07.003_bib0111","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1601-183X.2007.00378.x","article-title":"Neurotrophic factors in Alzheimer's disease: role of axonal transport","volume":"7","author":"Schindowski","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0112","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0361-9230(96)00039-1","article-title":"The effect of ibogaine on sigma- and NMDA-receptor- mediated release of [3H]dopamine","volume":"40","author":"Sershen","year":"1996","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0113","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3390\/ijms23042021","article-title":"Targeting the unfolded protein response as a disease-modifying pathway in dementia","volume":"23","author":"Sidhom","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0114","doi-asserted-by":"crossref","first-page":"eabb1717","DOI":"10.1126\/scitranslmed.abb1717","article-title":"Endosomal recycling reconciles the Alzheimer's disease paradox","volume":"12","author":"Small","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0115","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid-beta and tau at synapses in Alzheimer's disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0116","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/FTD.0b013e31828741a5","article-title":"Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities","volume":"35","author":"Stebelska","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0117","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/tnsci-2016-0007","article-title":"The serotonergic system and cognitive function","volume":"7","author":"Svob Strac","year":"2016","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0118","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fimmu.2015.00358","article-title":"Psychedelics and immunomodulation: novel approaches and therapeutic opportunities","volume":"6","author":"Szabo","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0119","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/s41598-018-20173-y","article-title":"Immunomodulatory capacity of the serotonin receptor 5-HT2B in a subset of human dendritic cells","volume":"8","author":"Szabo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106533","article-title":"Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells","volume":"9","author":"Szabo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0121","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fnins.2016.00423","article-title":"The endogenous hallucinogen and trace amine N,N-dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells","volume":"10","author":"Szabo","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0122","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbi.2021.10.017","article-title":"Increased circulating IL-18 levels in severe mental disorders indicate systemic inflammasome activation","volume":"99","author":"Szabo","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0123","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jnr.10441","article-title":"Neuroplasticity in Alzheimer's disease","volume":"70","author":"Teter","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0124","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.R800019200","article-title":"Amyloid precursor protein trafficking, processing, and function","volume":"283","author":"Thinakaran","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2020.10.001","article-title":"Psychedelics as a novel approach to treating autoimmune conditions","volume":"228","author":"Thompson","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0126","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.apsb.2021.11.003","article-title":"Mitochondrial complex I as a therapeutic target for Alzheimer's disease","volume":"12","author":"Trushina","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0127","doi-asserted-by":"crossref","first-page":"22468","DOI":"10.1073\/pnas.0909089106","article-title":"Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway","volume":"106","author":"Tsai","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0128","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s11064-020-03153-5","article-title":"The chronic treatment with 5-HT2A receptor agonists affects the behavior and the BDNF system in mice","volume":"45","author":"Tsybko","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0129","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1523\/JNEUROSCI.17-08-02785.1997","article-title":"5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex","volume":"17","author":"Vaidya","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","article-title":"Amyloid-beta-independent regulators of tau pathology in Alzheimer disease","volume":"21","author":"van der Kant","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0131","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnsyn.2020.00034","article-title":"Psychedelics as a treatment for Alzheimer's disease dementia","volume":"12","author":"Vann Jones","year":"2020","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0132","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.727117","article-title":"Psychedelics and other psychoplastogens for treating mental illness","volume":"12","author":"Vargas","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0133","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/a-1721-2914","article-title":"Classic psychedelic drugs: update on biological mechanisms","volume":"55","author":"Vollenweider","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0134","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0135","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3389\/fpsyg.2017.01657","article-title":"Dynamic brains and the changing rules of neuroplasticity: implications for learning and recovery","volume":"8","author":"Voss","year":"2017","journal-title":"Front Psychol"},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0136","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41467-017-02794-5","article-title":"Epigenetic modulation of inflammation and synaptic plasticity promotes resilience against stress in mice","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0137","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","article-title":"Neuronal activity enhances tau propagation and tau pathology in vivo","volume":"19","author":"Wu","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0138","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3389\/fnins.2020.00660","article-title":"GABAergic inhibitory interneuron deficits in Alzheimer's disease: implications for treatment","volume":"14","author":"Xu","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.07.003_bib0139","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fphar.2015.00225","article-title":"The role of serotonin 5-HT2A receptors in memory and cognition","volume":"6","author":"Zhang","year":"2015","journal-title":"Front. Pharmacol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X23001347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X23001347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:06:22Z","timestamp":1760378782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X23001347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":139,"alternative-id":["S0924977X23001347"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.07.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of psychedelics for the treatment of Alzheimer's disease and related dementias","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}